Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Doccole on Apr 04, 2021 12:57pm

Hoping for a rise

We are flat and we need catalysts! Ind application did nothing.  Nice to know that everything is in process and the 55,000 pages of rigor paid off!  

What could be causing the amalgamation to be so slow? Sounded like there was progress last month....this was announced in December!

looking forward to a GUD LATAM deal that will start us going again!

have a happy holiday all!

Comment by bringon10bagger on Apr 04, 2021 1:16pm
Lack of interest could be explained by the runway keeping to get longer enoute to finsh line of FDA approval......HOWEVER, depending on your finish line aspirations we could  see advancement to the backstrech with a BP deal at ANYTIME......this coming week or month(s)......... sitting tight!
Comment by Doccole on Apr 04, 2021 3:50pm
I get with that logic. My plan is sell 1/2 upon pharm deal, and hold 1/2 for either a full buyout or results.  I do believe something will be done prior or during the phase 3 trial.  Any other strategies for fellow longs?
Comment by RjM2018 on Apr 04, 2021 10:37pm
I've been holding since before phase 1 and have added significantly over the years.  I'm curious about what you mean by pharm deal? Does this mean deals for Otena in: Latin America, Europe, & or USA? If we strike a pharma deal for Otena in LATM, Eur, and USA, without any advancement of our other products I will likely sell 65-75% of my stock. Rationale: big pharma won't ...more  
Comment by Marky1 on Apr 04, 2021 11:00pm
Hold your shares,RJM until a buyout agreement is announced, my opinion, Once an announcement is announced, and I'm confident that it will be done before year end, thanks to the advice of Dr. Haut, who is on the advisory comit of partnership, this stock will shoot up to the 50++$. Range Best of luck longs! Hoping for some positive PR this week!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities